XML 35 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Transactions - Additional Information (Detail) (USD $)
1 Months Ended 3 Months Ended 5 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 5 Months Ended 12 Months Ended 1 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended
Aug. 31, 2011
Mar. 31, 2012
Dec. 31, 2012
Dec. 31, 2012
Dec. 31, 2011
Nov. 30, 2012
Oct. 31, 2012
Feb. 29, 2012
Stock Option [Member]
Jul. 31, 2012
Five Year Warrants [Member]
Mar. 31, 2012
Five Year Warrants [Member]
Dec. 31, 2012
Five Year Warrants [Member]
Dec. 31, 2012
Five Year Warrants [Member]
Dec. 31, 2012
Five Year Warrants [Member]
Exercise Price 0.0745 [Member]
Dec. 31, 2012
Five Year Warrants [Member]
Exercise Price0.1287 [Member]
Dec. 31, 2012
Common Stock [Member]
Dec. 31, 2011
Common Stock [Member]
Feb. 28, 2011
Common Stock [Member]
Jan. 31, 2011
Series B Convertible Preferred Stock [Member]
Dec. 31, 2011
Series B Convertible Preferred Stock [Member]
Dec. 31, 2010
Series B Convertible Preferred Stock [Member]
Feb. 28, 2011
Series C Convertible Preferred Stock [Member]
Dec. 31, 2012
Series C Convertible Preferred Stock [Member]
Dec. 31, 2011
Warrant [Member]
Dec. 31, 2012
Warrant [Member]
Oct. 31, 2012
Agent [Member]
Five Year Warrants [Member]
Dec. 31, 2012
Agent [Member]
Five Year Warrants [Member]
Dec. 31, 2011
Former Holder [Member]
Dec. 31, 2012
Convertible Debentures
Numbers
Oct. 31, 2012
Restricted Stock [Member]
Jul. 31, 2012
Restricted Stock [Member]
Oct. 31, 2012
Restricted Stock [Member]
Vendor [Member]
Dec. 31, 2012
Restricted Stock [Member]
Vendor [Member]
Dec. 31, 2011
Restricted Stock [Member]
Director [Member]
Stockholders Equity Note [Line Items]                                                                  
Common Stock granted during period                                           4,746,667                      
Common stock granted during period exercise price       $ 0.12 $ 0.10     $ 0.09                           $ 0.12                      
Percentage of options vest at grant                                           25.00%                      
Vesting period                                           3 years                      
Debt Instrument, Face Amount   $ 2,350,527 $ 1,003,158 $ 1,003,158                                               $ 2,224,212          
Debt Instrument, Convertible, Number of Equity Instruments                                                       38,817,018          
Accrued interest related to debentures                                                       222,474          
Debt Instrument Convertible Interest Expense Number Of Equity Instruments issued                                                       3,881,693          
Common Stock issued for services (in shares)                 50,000           1,475,000 42,222                 25,000   1,733     50,000 25,000 1,400,000 8,000
Common Stock issued for services       81,500 86,405       8,500           14,750 422                           8,500 3,000 70,000  
Warrants Issued To Purchase Common Stock 1,485,838                 20,511,000 5,066,000 25,577,000                                 14,870        
Warrants Issued As Compensation                                                   7,673,000              
Warrants Issued                         26,664,000 6,586,000                                      
Warrants Exercise Price One                   $ 0.0745   $ 0.0745                                          
Warrants Exercise Price Two                     $ 0.1287 $ 0.1287                                          
Number Of Cashless Warrants To Purchase Common Stock                                                         86,340        
Conversion price at maturity   $ 0.0573 $ 0.099 $ 0.099   $ 0.099 $ 0.099                                 $ 0.0573                  
Warrants Maturity Period   five-year five-year                                                            
Option To Purchase Common Stock               500,000                                                  
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights               The option vests 25% at grant and 1/36 of the remaining grant amount monthly for three years.                                                  
Stock Issued During Period, Shares, New Issues                                                     4,333           42,222
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized                                 348,392                                
Accumulated and Unpaid Dividend                                     106,931 106,931                          
Convertible Preferred Stock, shares outstanding                                     2,535,000   1,000,000                        
Preferred Stock Conversion Price                                   $ 0.2     $ 0.20                        
Warrants Exercise Price $ 0.08                                                                
Noncash Operating Expenses                                             $ 78,000